- Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, is a global leader in scientific instrumentation and biopharma services, reporting $44.56 billion in revenue for 2025 with a 4% year-over-year growth.
- In 2025, the company launched innovative products such as the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer, contributing to a fourth quarter revenue increase of 7% to $12.21 billion.
- Thermo Fisher serves a diverse customer base including academic institutions and pharmaceutical companies, facing challenges from cuts in U.S. academic research funding that may impact future sales.
- The ideal buyer for Thermo Fisher's products includes research institutions and biopharma companies looking for advanced scientific solutions, particularly as they navigate funding pressures and seek innovative technologies to enhance their research capabilities.
Thermo Fisher Scientific's workforce is organized into 19 departments, with Operations being the largest at 7,645 employees, followed by Information Technology with 4,924 and Community and Social Services at 3,597. This diverse departmental structure indicates a strong emphasis on operational efficiency and technological support, essential for a company in the scientific equipment industry. The presence of significant headcounts in Sales and Engineering further reflects the company's focus on product development and market outreach.
The company's workforce is distributed across 1,528 locations, with the largest concentration in Waltham, MA, housing 3,207 employees. Other notable locations include Carlsbad, CA, with 878 employees, and San Diego, CA, with 686 employees. The substantial headcount categorized as 'Other' suggests a significant remote or distributed workforce, indicating Thermo Fisher's ability to operate effectively across various geographic regions while maintaining a centralized operational hub.
